Ole Nielsen, PhD, CEO & Co-founder of GO-Pen, is on a health moonshot mission to create equal access to quality diabetes care. By making insulin pens affordable for everyone, GO-Pen – a member of StartUp Health's T1D Moonshot Community – is replacing the use of syringes and making diabetes management easier and less expensive for millions globally. 🏆 GO-Pen won the 2023 ADA Innovation Challenge, and they are progressing towards FDA and CE mark clearance. 💉 Introduction of the insulin pen has revolutionized diabetes management, making it more convenient and accessible. 💡 Ole Nielsen, PhD, has 31 insulin pen patents, making him a key figure in the industry. 🏥 People using the ER for medical care are the most expensive patients in the health system. 💉 11-15 million people worldwide use syringes; GO-Pen's innovation targets this large market. 📈 Not competing with existing insulin pens but improving insulin vials; potential savings of $6 billion yearly in the US alone. 🤝 GO-Pen plans to secure more investments and partnerships, aiming for global impact in diabetes care. 💼 The company has secured a guarantee from the European Union to invest, which is a unique opportunity for funding. 😌 Embracing a positive attitude in difficult times can be a challenge, but it's important for a CEO to spread that can-do attitude to the team. 🌍 We need to join forces internationally to ensure equitable access to healthcare for all.